Medical Education Library

Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment


 

Click Here to Read the Supplement.

Topics include:

  • Medications for Type 2 Diabetes Mellitus: A Work in Progress
  • Role of Injectable Medications in Type 2 Diabetes Treatment
  • Basal Insulins
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist

Click Here to Read the Supplement.

Recommended Reading

The 3 Reasons Patients With Diabetes Don’t Get Eye Care
Type 2 Diabetes ICYMI
Diabetes medications and cardiovascular outcome trials: Lessons learned
Type 2 Diabetes ICYMI
Is obesity a disease?
Type 2 Diabetes ICYMI
Empagliflozin’s effects independent of CVD risk factors
Type 2 Diabetes ICYMI
Delayed-release metformin proves promising for diabetic renal disease
Type 2 Diabetes ICYMI
FDA approves first non–finger-stick glucose monitoring system
Type 2 Diabetes ICYMI
Skin autofluorescence predicts 4-year CVD risk in diabetes
Type 2 Diabetes ICYMI
New ADA hypertension and diabetes treatment guide features visual aid
Type 2 Diabetes ICYMI
Many years on metformin linked to anemia risk
Type 2 Diabetes ICYMI
Optimal Treatment of Patients With Diabetes
Type 2 Diabetes ICYMI